Third-quarter total revenue rose 10%, while diagnostic testing revenue increased 16% and test volumes grew 24%. Gross margin was 81%.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.